Clover Health Investments Corp’s filing revealed that its Director Edwards Carladenise Armbrister unloaded Company’s shares for reported $0.72 million on Mar 07 ’25. In the deal valued at $3.61 per share,200,000 shares were sold. As a result of this transaction, Edwards Carladenise Armbrister now holds 273,227 shares worth roughly $1.04 million.
Then, Priest Brady Patrick sold 75,000 shares, generating $276,000 in total proceeds. Upon selling the shares at $3.68, the CEO of Home Care now owns 2,418,151 shares.
Before that, Soares Karen sold 52,500 shares. Clover Health Investments Corp shares valued at $199,500 were divested by the General Counsel & Secretary at a price of $3.80 per share. As a result of the transaction, Soares Karen now holds 1,299,663 shares, worth roughly $4.95 million.
Craig Hallum initiated its Clover Health Investments Corp [CLOV] rating to a Buy in a research note published on December 17, 2024; the price target was $6. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early October with a ‘”a Neutral”‘ rating. Cowen also remained covering CLOV and has increased its forecast on February 02, 2022 with a “Market perform” recommendation from previously “an Underperform” rating. Canaccord Genuity started covering the stock on February 02, 2022. It rated CLOV as “a Buy”.
Price Performance Review of CLOV
On Tuesday, Clover Health Investments Corp [NASDAQ:CLOV] saw its stock jump 2.97% to $3.81. Over the last five days, the stock has gained 13.39%. Clover Health Investments Corp shares have risen nearly 20.95% since the year began. Nevertheless, the stocks have risen 425.52% over the past one year. While a 52-week high of $4.87 was reached on 01/24/25, a 52-week low of $0.61 was recorded on 01/02/25. SMA at 50 days reached $4.09, while 200 days put it at $3.03.
Levels Of Support And Resistance For CLOV Stock
The 24-hour chart illustrates a support level at 3.66, which if violated will result in even more drops to 3.52. On the upside, there is a resistance level at 3.89. A further resistance level may holdings at 3.98. The Relative Strength Index (RSI) on the 14-day chart is 47.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 54.83%. Stochastics %K at 38.48% indicates the stock is a holding.
How much short interest is there in Clover Health Investments Corp?
A steep rise in short interest was recorded in Clover Health Investments Corp stocks on 2025-02-28, dropping by -3.19 million shares to a total of 11.9 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 15.08 million shares. There was a decline of -26.78%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 19, 2022 when SVB Leerink began covering the stock and recommended ‘”a Mkt perform”‘ rating along with a $3 price target.
